trapidil has been researched along with Chronic Disease in 4 studies
Trapidil: A coronary vasodilator agent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Overall results of this study show that both drugs are equally effective and safe for the short-term treatment of patients with chronic stable angina pectoris and that trapidil can be considered as therapeutically equivalent to ISDN." | 9.12 | Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study. ( Lehmacher, W; Meinertz, T, 2006) |
| "Overall results of this study show that both drugs are equally effective and safe for the short-term treatment of patients with chronic stable angina pectoris and that trapidil can be considered as therapeutically equivalent to ISDN." | 5.12 | Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study. ( Lehmacher, W; Meinertz, T, 2006) |
| "Trapidil was given orally (200 mg, Rocornal dragees 100 mg) as well as intravenously (100 mg) in random order." | 2.67 | Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease. ( Berndt, A; Pönicke, K; Weiss, M, 1992) |
| "Trapidil was administered intravenously as a 100-mg bolus." | 1.29 | Pharmacokinetics of trapidil in patients with chronic liver disease. ( Berndt, A; Looby, M; Pönicke, K; Weiss, M; Zipprich, B, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meinertz, T | 1 |
| Lehmacher, W | 1 |
| Ikeda, H | 1 |
| Takahashi, K | 1 |
| Sato, S | 1 |
| Sasaki, H | 1 |
| Ito, E | 1 |
| Yasui, S | 1 |
| Berndt, A | 2 |
| Looby, M | 1 |
| Pönicke, K | 2 |
| Zipprich, B | 1 |
| Weiss, M | 2 |
2 trials available for trapidil and Chronic Disease
| Article | Year |
|---|---|
Trapidil is as effective as isosorbide-dinitrate for treating stable angina pectoris: a multinational, multicenter, double-blind, randomized study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Exercise Test; E | 2006 |
Pharmacokinetics of trapidil (Rocornal) in patients with chronic liver disease.
Topics: Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Liver Cirrhosis; Liver Diseas | 1992 |
2 other studies available for trapidil and Chronic Disease
| Article | Year |
|---|---|
Bronchodilatory effect of trapidil in man.
Topics: Adult; Aged; Asthma; Blood Gas Analysis; Bronchitis; Bronchodilator Agents; Chronic Disease; Female; | 1984 |
Pharmacokinetics of trapidil in patients with chronic liver disease.
Topics: Adult; Aged; Biological Availability; Chromatography, High Pressure Liquid; Chronic Disease; Confide | 1996 |